These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 11252655)

  • 1. Serotonin in mania and in the mechanism of action of mood stabilizers: a review of clinical studies.
    Shiah IS; Yatham LN
    Bipolar Disord; 2000 Jun; 2(2):77-92. PubMed ID: 11252655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allopurinol for mania: a randomized trial of allopurinol versus placebo as add-on treatment to mood stabilizers and/or antipsychotic agents in manic patients with bipolar disorder.
    Weiser M; Burshtein S; Gershon AA; Marian G; Vlad N; Grecu IG; Tocari E; Tiugan A; Hotineanu M; Davis JM
    Bipolar Disord; 2014 Jun; 16(4):441-7. PubMed ID: 24712840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Employing pharmacologic treatment of bipolar disorder to greatest effect.
    Schatzberg AF
    J Clin Psychiatry; 2004; 65 Suppl 15():15-20. PubMed ID: 15554791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of serotonin in the pathophysiology of depression: focus on the serotonin transporter.
    Owens MJ; Nemeroff CB
    Clin Chem; 1994 Feb; 40(2):288-95. PubMed ID: 7508830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Quetiapin in bipolar disorders].
    Sümegi A
    Neuropsychopharmacol Hung; 2008 Dec; 10(5):281-91. PubMed ID: 19419014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycogen Synthase Kinase-3β as a Putative Therapeutic Target for Bipolar Disorder.
    Dandekar MP; Valvassori SS; Dal-Pont GC; Quevedo J
    Curr Drug Metab; 2018; 19(8):663-673. PubMed ID: 29283064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lithium augmentation in treatment-resistant depression: clinical evidence, serotonergic and endocrine mechanisms.
    Bschor T; Lewitzka U; Sasse J; Adli M; Köberle U; Bauer M
    Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S230-4. PubMed ID: 14677084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotonergic dysregulation in bipolar disorders: a literature review of serotonergic challenge studies.
    Sobczak S; Honig A; van Duinen MA; Riedel WJ
    Bipolar Disord; 2002 Dec; 4(6):347-56. PubMed ID: 12519094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Guidelines for the prescription of mood stabilizers for adolescents: A literature review].
    Munch G; Godart N
    Encephale; 2017 Oct; 43(5):464-470. PubMed ID: 27871720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated theory to unify status among schizophrenia and manic depressive illness.
    Fukuda K
    Med Hypotheses; 2015 Oct; 85(4):506-11. PubMed ID: 26141636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of antipsychotic drugs and lithium in mania.
    Cookson J
    Br J Psychiatry Suppl; 2001 Jun; 41():s148-56. PubMed ID: 11450176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of mood stabilizers and antipsychotics in the maintenance phase of bipolar disorder: a systematic review of randomized controlled trials.
    Smith LA; Cornelius V; Warnock A; Bell A; Young AH
    Bipolar Disord; 2007 Jun; 9(4):394-412. PubMed ID: 17547586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormalities in protein kinase C signaling and the pathophysiology of bipolar disorder.
    Hahn CG; Friedman E
    Bipolar Disord; 1999 Dec; 1(2):81-6. PubMed ID: 11252663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Neurotransmitter Alterations in Four Distinct Brain Regions After Rapid Eye Movement Sleep Deprivation (REMSD) Induced Mania-Like Behaviour in Swiss Albino Mice.
    Siddique SA; Tamilselvan T; Vishnupriya M; Balamurugan E
    Neurochem Res; 2018 Jun; 43(6):1171-1181. PubMed ID: 29671235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential mechanisms of action of lithium in bipolar disorder. Current understanding.
    Malhi GS; Tanious M; Das P; Coulston CM; Berk M
    CNS Drugs; 2013 Feb; 27(2):135-53. PubMed ID: 23371914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mood stabilizers--past, present and future].
    Sümegi A
    Neuropsychopharmacol Hung; 2008 Mar; 10(1):31-42. PubMed ID: 18771018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is the brain arachidonic acid cascade a common target of drugs used to manage bipolar disorder?
    Bazinet RP
    Biochem Soc Trans; 2009 Oct; 37(Pt 5):1104-9. PubMed ID: 19754461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute and maintenance treatment with mood stabilizers.
    Bowden CL
    Int J Neuropsychopharmacol; 2003 Sep; 6(3):269-75. PubMed ID: 12974993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative efficacy and acceptability of combined antipsychotics and mood stabilizers versus individual drug classes for acute mania: Network meta-analysis.
    Glue P; Herbison P
    Aust N Z J Psychiatry; 2015 Dec; 49(12):1215-20. PubMed ID: 26546499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mood stabilizer treatment increases serotonin type 1A receptor binding in bipolar depression.
    Nugent AC; Carlson PJ; Bain EE; Eckelman W; Herscovitch P; Manji H; Zarate CA; Drevets WC
    J Psychopharmacol; 2013 Oct; 27(10):894-902. PubMed ID: 23926239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.